Objective-Intravenous lipid use is associated with an acute hyperlipidemia, but long-term consequences have not been studied. We investigated whether elevated lipids in humans during the critical period of preterm neonatal life have a long-term impact on aortic and myocardial function relevant to adult disease. Methods and Results-We followed up 102 subjects born prematurely and now aged 23 to 28 years. Eighteen received intravenous lipids as neonates and were matched to controls with equivalent perinatal characteristics. Global and regional aortic stiffness and left ventricular function were assessed by cardiovascular magnetic resonance. Those who received intravenous lipids had greater aortic stiffness in early adulthood (Pϭ0.0002), with greater stiffness in the abdominal aorta (Pϭ0.012). The relationship was graded according to the elevation in neonatal cholesterol induced by intravenous lipids (PϽ0.0001) but not other metabolic parameters altered by the infusion. Peak systolic circumferential strain was also reduced in the lipid group (Pϭ0.006), which, again, was proportional to neonatal cholesterol level (PϽ0.01). Key Words: aortic development Ⅲ cholesterol Ⅲ early development Ⅲ myocardial function Ⅲ young adults H yperlipidemia is a key biological driver for atherogenesis. 1-3 Lipid-rich fatty streaks first emerge in the aortic wall during fetal life and peak in prevalence during the first year following birth. 4,5 Newborn offspring of hypercholesterolemic mothers who have been exposed to abnormal lipid profiles have significantly more aortic fatty streaks which persist into adolescence. 6 Whether changes in the cardiovascular system are seen in those without a maternal history of hypercholesterolemia or those who are exposed to hyperlipidemia after birth is unknown but of potential importance because of its clinical relevance to a broader population and postnatal nutrition.
H yperlipidemia is a key biological driver for atherogenesis. [1] [2] [3] Lipid-rich fatty streaks first emerge in the aortic wall during fetal life and peak in prevalence during the first year following birth. 4, 5 Newborn offspring of hypercholesterolemic mothers who have been exposed to abnormal lipid profiles have significantly more aortic fatty streaks which persist into adolescence. 6 Whether changes in the cardiovascular system are seen in those without a maternal history of hypercholesterolemia or those who are exposed to hyperlipidemia after birth is unknown but of potential importance because of its clinical relevance to a broader population and postnatal nutrition.
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Therefore, we studied young adults whose mothers were normocholesterolemic but who were born prematurely and, as part of their routine clinical care, had received a brief, artificial, nutritional elevation in lipid levels postnatally in the form of an intravenous lipid infusion. Intralipid is widely used in parenteral nutrition as a source of energy and essential fatty acids. It consists of triglycerides in the form of soybean oil emulsified by egg phospholipid and glycerol. 7 Hypercholesterolemia secondary to Intralipid use is well described, likely driven by endogenous cholesterol synthesis as a result of delayed lipid clearance. [7] [8] [9] Because fatty streaks first appear in the aorta, 5 and in animal models arterial stiffness is the first pathophysiological change that occurs during this process, 10 we studied global aortic stiffness in early adulthood, measured as pulse wave velocity (PWV), a measure known to be relevant to later cardiovascular outcome in large-scale studies. 11 We used cardiovascular magnetic resonance imaging, 12 which, as it images the aorta directly, also allowed us to study regional variation in aortic stiffness. We used this information to determine whether the abdominal aorta, known to be most affected by fatty streaks in early life, had the greatest changes in aortic stiffness.
Furthermore, because animal models have also shown a direct relationship between diet-induced hyperlipidemia and myocardial dysfunction, 13, 14 we determined whether lipid exposure has effects beyond the vasculature and used cardiovascular magnetic resonance to study long-term variation in left ventricular structure and function.
Methods

Study Population
We performed a 25-year prospective follow-up study of a preterm cohort enrolled into a randomized trial of milk feeding regimes in 5 centers in the United Kingdom between 1982 and 1985. 15 Participants were born weighing less than 1850 g, and obstetric and neonatal details recorded at birth including detailed information on interventions during their hospital stay and biochemical analysis of blood samples (including lipid levels) collected during the first 9 weeks of life. 16 In addition to being randomized to banked breast milk or feeding formula, intravenous lipids were given simultaneously to newborns in this cohort on the basis of variable local guidelines and they received commercially available 10% or 20% Intralipid. Individuals were given up to 2 to 3 g/kg per day of Intralipid, conforming to Intralipid administration practice at that time. 9, 17, 18 Follow-up of the children had been performed at 18 months 19 and 7 years, 20 with a substudy at 15 years. 16 The initial preterm cohort consisted of 927 subjects ( Figure 1 ). We recontacted 240 individuals from the preterm cohort who had agreed to be contacted about future studies, of whom 102 were able to attend an appointment at the Department of Cardiovascular Medicine, University of Oxford, for characterization of cardiovascular risk and to undergo cardiac and vascular imaging. In addition, we recruited a control group of age-and sex-matched healthy volunteers born at term who were not exposed to postnatal intravenous lipids to provide normal reference ranges for the cardiac and aortic measures, performed using the same techniques, in our laboratory. All studies were approved by relevant ethics committees, and participants provided signed informed consent.
Demographics and Metabolic Characteristics
All subjects attended in the morning following a 12-hour overnight fast. Height was measured without shoes to the nearest 1 cm and weight to the nearest 0.2 kg, with subjects wearing light clothing, using a combined digital height and weight measurement station (Seca). Hip and waist circumferences were measured with a tape measure. Data on medical history, smoking, and parental medical history were obtained by questionnaire. 21 Blood samples were drawn, centrifuged and separated within 30 minutes, and then stored for later analysis at Ϫ80°C. Fasting blood glucose, total cholesterol, high-density lipoprotein cholesterol, and triglycerides were measured at the Oxford John Radcliffe Hospital Biochemistry Laboratory using routine validated assays, with clinical-level quality controls. Low-density lipoprotein cholesterol was calculated using the Friedewald formula. Three measurements of brachial blood pressure were recorded for each participant with an Omron automatic digital monitor (HEM-705CP) using the appropriate cuff size for arm circumference and averaged for analysis. 15 To assess central blood pressure, radial artery applanation tonometry was used to derive ascending aortic pressure waveforms and blood pressure estimated on the basis of a commercially available transfer function of brachial blood pressure (SphygmoCor Analysis System, Sydney, Australia). 15 
Aortic PWV
Global aortic stiffness was assessed by aortic PWV measured using cardiovascular magnetic resonance on a 1.5-Tesla (Sonata, Siemens) Figure 1 . Preterm study cohort. Two hundred forty individuals with agreement to be recontacted from a cohort of 927 preterm-born individuals (birth weight Ͻ1850 g) were followed up in adolescence. One hundred two of these individuals were seen in young adulthood to undergo cardiovascular phenotyping. Individuals who received intravenous (IV) lipids and those that did not were matched in a 1:2 ratio based on early life characteristics, with 18 who received intravenous lipids and 36 who did not.
scanner. Aortic PWV was chosen as our primary outcome measure as, biologically, arterial stiffness is of most relevance to early vascular changes related to lipids, 22, 23 and we have previously shown that aortic PWV measured with cardiovascular magnetic resonance is highly reproducible. 24 Images were captured by a single observer using a free-breathing, retrospectively ECG-gated, spoiled gradient echo sequence. Velocity-encoding gradient for phase contrast was applied to measure through-plane flow in the ascending aorta at the level of the pulmonary artery and the descending aorta 11 cm vertically down from this just below the diaphragm. Image analysis was performed using Siemens analytic software (Argus, Siemens Medical Solutions, Erlangen, Germany). Flow images were manually contoured as previously described. 24 Aortic PWV was calculated as the distance between the assessed sites of the aorta (measured on an aortic oblique sagittal image; Figure 2A ) divided by the time delay between the arrival of the foot of the pulse wave at each site. Aortic PWV was therefore calculated along the entire length of the thoracic aorta, from the ascending to the distal descending site. We defined the arrival of the foot of the pulse wave as the intersection of the tangent (determined by a least-squares method of the 4 flow points around the half-maximal point of flow) of the upslope of the flow curve with the x-axis (time).
Aortic Distensibility
To gain insight into regional changes in aortic stiffness, we assessed aortic distensibility in 3 different positions along the aorta. An image obtained at the level of the right pulmonary artery allowed for the cross-sectional assessment of the ascending and proximal descending aorta ( Figure 2A) . A second image at the level of the second lumbar vertebrae provided a cross-section of the abdominal aorta. ECGgated, steady-state free precession (SSFP) "cine" images were acquired during breath-hold to determine aortic distensibility. Maximum and minimum aortic cross-sectional areas over the cardiac cycle were determined using semiautomated edge detection algorithms developed using Matlab software (Mathworks Inc), and distensibility was calculated as the relative change in area divided by the pulse pressure as previously described. 25 Pulse pressure was derived using Sphygmocor central blood pressure measures (SphygmoCor Analysis System).
Left Ventricular Mass
Cardiac imaging was prospectively ECG gated with a precordial 3 lead ECG and acquired during end-expiration breath holding. SSFP cine sequences were used to acquire localization images followed by a SSFP left ventricular short-axis stack to obtain coverage of the entire left ventricle with a slice thickness of 7 mm and an interslice gap of 3 mm. Analysis of left ventricular mass indexed for body surface area was performed with Argus Syngo MR software (version B15, Siemens Healthcare, Erlangen, Germany) using the short-axis SSFP images as previously described. 26 
Left Ventricular Systolic Function
The left ventricular short-axis stack was also used to assess ejection fraction on the basis of end-diastolic and end-systolic endocardial contour analysis using Argus Syngo MR. Furthermore, in a subgroup, we assessed left ventricular myocardial deformation with tagging sequences in basal, mid-, and apical short-axis SSFP images, as changes in strain are often observed before the development of changes in left ventricular mass or ejection fraction. 27 All data were analyzed by a single experienced operator, with an intraobserver coefficient of variance of 2.05% (Pϭ0. .0002) at age 0 to 9 weeks. C, Regional differences in aortic distensibility. There were no differences between those who did and did not receive IV lipids during early postnatal life in ascending aortic or proximal descending aortic distensibility, although descending abdominal aortic distensibility was greatly reduced in the group that received IV lipids (9.74Ϯ4.27 vs 12.91Ϯ4.11 mm Hg Ϫ1 ϫ10 3 , Pϭ0.012).
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Statistical analysis was carried out using SPSS (Statistical Package for the Social Sciences, Version 18) and GraphPad Prism, version 5. We identified 18 participants in the study cohort as having received intravenous lipids at birth. To limit the confounding effect of other potential variables at birth related to the clinical decision to give intravenous lipids, we identified for each case 2 controls who had not received intravenous lipids but who had similar gestational age, birth weight z-score, sex, key maternal risk factors, pregnancy complications, and postnatal complications ( Table) . We determined that 36 preterm controls would provide us with 95% power at Pϭ0.05 to identify a 1.04-SD difference in aortic PWV between preterm groups, similar to the differences we have previously observed between risk factor groups. 28 
Results
Population Characteristics in Early Postnatal Life
We confirmed that clinical infant neonatal characteristics were the same in each recruitment center but that there was significant variation in whether a center used intravenous lipids (Supplemental Table I , available online at http:// atvb.ahajournals.org). As a result, we were able to match those who received intravenous lipids with individuals who had identical perinatal characteristics but did not receive intravenous lipids. The Table demonstrates that the preterm 
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subjects included in the analysis who had or had not received intravenous lipids were closely matched for all maternal, labor, and postnatal characteristics. Furthermore, as the preterm individuals had been randomized to milk feeding regimes, other dietary intakes were matched between those who did and did not receive intravenous lipids (Supplemental Table II ). There were no differences in the number of individuals in our preterm groups in terms of prenatal steroids exposure (Table) or postnatal minimum, mean, or maximum cortisol levels (Supplemental Table III ). Thyroid function as assessed by postnatal minimum, mean, and maximum triiodothyronine levels did not differ between the groups (Supplemental Table III ). Our comparison group of term-born individuals also showed no difference in sex, maternal characteristics, and smoking during pregnancy from our preterm groups, although gestational age, birth weight z-score, percentage born small for gestational age, and number of individuals whose mothers had gestational hypertension or preeclampsia differed as expected (Table) .
Population Characteristics in Young Adult Life
In early adult life, there were no significant differences between groups in age, blood pressure, anthropometry, smoking history, lipid profile, measures of glucose homeostasis, or other biochemistry measures (Supplemental Table IV ). Our term-born group was aged 25.35Ϯ1.75 years and had an average body mass index of 23.47Ϯ2.27 kg/m 2 ; thus, neither of these 2 parameters differed across our 3 groups (ANOVA Pϭ0.859 and 0.214, respectively). There were no differences between the groups in terms of parent or grandparent family medical history (Supplemental Tables 1 and V) , and no differences between the groups in terms of diet, medical history, alcohol intake, exercise, or sociodemographics (results not shown). Figure 2B demonstrates that preterm infants who received intravenous lipids at birth had a 29% greater aortic PWV in early adulthood (5.89Ϯ1.23 versus 4.57Ϯ1.17 m/s, Pϭ0.0002). Aortic PWV in our term-born controls was 4.48Ϯ0.66 m/s, which was similar to our preterm controls (Pϭ0.677) but significantly lower than in those who had received intravenous lipids (PϽ0.0001). We then used information on regional aortic distensibility to determine which areas of the aorta had the greatest change in aortic stiffness. Figure 2C demonstrates that a significant reduction in distensibility was evident in the abdominal aorta (9.74Ϯ4.27 versus 12.91Ϯ4.11 mm Hg , which was similar to our preterm controls (Pϭ0.468) but significantly higher than the preterm intravenous lipid group (Pϭ0.003).
Aortic Function
Intravenous Lipid Administration
Association Between Intravenous Lipids, Neonatal Biochemistry, and Aortic Stiffness As intravenous lipid administration is known to alter a range of circulating metabolic parameters we explored relationships between 3 different intravenous lipid parameters and maximum 
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cholesterol, triglyceride, glucose, and phospholipid levels during the first 9 weeks of life. Figure 3A demonstrates that, as expected, maximum cholesterol, triglyceride, glucose, and phospholipid levels were all significantly associated (PϽ0.05) with at least 1 of the intravenous lipid parameters. However, only maximum cholesterol level was related to both intravenous lipid administration and our primary end point of aortic PWV in young adulthood (rϭ0.616, 95% CI 0.029 to 0.061, PϽ0.0001). Figure 3B shows the graded relationship between postnatal maximum cholesterol and aortic PWV. We then separated the preterm individuals who did and did not receive intravenous lipids to determine the association between postnatal maximum cholesterol and aortic PWV in each group. Figure 3C demonstrates that there was a graded association between aortic PWV in young adult life and the level of cholesterol obtained in the Intralipid group (rϭ0.728, 95% CI 0.020 to 0.059, Pϭ0.001) with a similar positive but nonsignificant graded association in the preterm group that did not receive intravenous lipids (rϭ0.345, Pϭ0.192). Figure 4A demonstrates that individuals given intravenous lipids had on average a 1.26 mmol/L higher maximum cholesterol level during neonatal life (Pϭ0.006), whereas minimum cholesterol levels were similar between groups at this age. Our data indicated that the maximum cholesterol level in our intravenous lipid group was likely to be representative of mean circulating cholesterol levels during Intralipid infusion, independent of native cholesterol levels. Intralipid was given postnatally for an average of 11.17Ϯ 10.02 days (rangeϭ2 to 36 days) and the area under the curve of cholesterol measurements during the 9-week period was closely related to the number of days on Intralipid and the dose of Intralipid given (rϭ0.789, PϽ0.001, and rϭ0.765, PϽ0.001, respectively). Figure 4B is an example of the cholesterol curve for 1 individual who received intravenous lipids for 33 days and had a corresponding sustained increase in cholesterol for a similar period of time before returning to a baseline cholesterol level. We compared our values of cholesterol in neonatal life to those reported by Sporik et al, who showed mean cholesterol values at birth of 1.8Ϯ0.5 mmol/L in healthy term-born infants. 29 This level was similar to the mean values for both our group that received Intralipid (1.73Ϯ0.7 mmol/L) and the group that did not receive Intralipid (1.82Ϯ0.6 mmol/L). Furthermore, cholesterol levels in adult life ( Figure 4A ) also did not differ between groups and were independent of maximum cholesterol level during the first 9 weeks. These findings indicate that underlying fasting lipid metabolism was similar between groups.
Intravenous Lipid and Cholesterol Levels in Neonatal and Adult Life
Early Cholesterol Levels and Other Predictors of PWV
We then explored the relative importance of early cholesterol levels compared with other predictors of aortic PWV in later life. Parameters with PϽ0.5 were included in a stepwise linear regression model (Supplemental Table VI ). In the case of blood pressure measurements, the one that most strongly associated to aortic PWV (mean arterial pressure) was included in the regression model, as all blood pressure measures were strongly interrelated. Aortic PWV was included as the dependent variable, with maximum cholesterol at age 0 to 9 weeks, mean arterial pressure, LDL cholesterol, body mass index, and smoking status in young adult life as independent variables. Maximum cholesterol from age 0 to 9 weeks was an independent predictor of aortic PWV in adult life (␤ϭ0.616, 95% CI 0.026 to 0.064, PϽ0.0001). We also ensured that there was no association between recruitment center and cardiovascular end points in those who did not receive intravenous lipids and repeated analysis excluding the recruitment center with the highest use of intravenous lipids. This did not alter the size of the association between intravenous lipid use and cardiovascular end points. . Individuals who received IV lipids achieved significantly higher maximum cholesterol levels during the first 9 weeks of life (4.38Ϯ1.65 vs 3.12Ϯ0.78 mmol/L, Pϭ0.006). There were no differences between the 2 groups in terms of minimum cholesterol levels in the first 9 weeks of life, fasting cholesterol at age 15 years and at age 25 years. B, An example of a cholesterol curve for an individual who received IV lipids for 33 days. As can be seen, the 2.5-fold increase in cholesterol elevation occurs over a 30-day period, and then the cholesterol level returns to baseline.
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Hierarchical multiple regression was used to assess the contribution of maximum neonatal cholesterol to the variation in adult aortic PWV. Mean arterial pressure, LDL cholesterol, body mass index, and smoking status in young adult life accounted for 11.6% of the variance in aortic PWV. Inclusion of maximum neonatal cholesterol increased this to 48.8% and therefore accounted for an additional 37.1% of the variance in aortic PWV (R 2 changeϭ0.371, F changeϭ24.633, PϽ0.0001). In this final model, the only statistically significant determinant of aortic PWV was the maximum cholesterol level (␤ϭ0.625, 95% CI 0.027 to 0.064, PϽ0.0001).
Cardiac Function
Intravenous Lipid Administration
We then tested the hypothesis that intravenous lipids were also associated with long-term changes in cardiac structure and function. There were no differences in left ventricular mass indexed for body surface area or ejection fraction in young adult life between those who received intravenous lipids and those who did not (body surface area: meanϮSDϭ59.44Ϯ8.56 versus 61.57Ϯ8.84 g/m 2 , Pϭ0.414; ejection fraction: 64.05Ϯ5.57 versus 64.00Ϯ6.82%, Pϭ0.980). Data collection on myocardial strain, a marker of subclinical variation in myocardial function, became technically possible in our center during the study and was available for a subgroup of subjects (7 who received intravenous lipids and 12 who did not). Figure 5A demonstrates that those who had received intravenous lipids had a significant reduction in myocardial left ventricular peak systolic apical CS in young adult life (17.91Ϯ3.29 versus 21.58Ϯ1.81%,
Pϭ0.006).
Apical CS in our term-born controls was 21.11Ϯ2.53%, which differed significantly from the preterm intravenous lipid group (Pϭ0.005) but was not significantly different from the preterm controls (Pϭ0.553). Figure 5B Figure 5C .
Association With Cholesterol Level
We then determined the nature of the associations between cholesterol level, intravenous lipid administration, and systolic strain. Apical CS was significantly associated with dose of intravenous lipids received (rϭϪ0.606, Pϭ0.006) and the number of days given intravenous lipids (rϭϪ0.506, Pϭ0.026) in early postnatal life. Similar to the association between maximum cholesterol level and aortic function, there was a graded association between maximum cholesterol level in the first 9 weeks of life and apical CS (rϭϪ0.574, Pϭ0.010), driven by the individuals who received Intralipid, but there were no associations with other biochemical parameters during neonatal life and myocardial function.
Myocardial and Aortic Function
Apical CS was also inversely associated with aortic PWV (rϭϪ0.562, Pϭ0.012) in early adulthood. We therefore explored whether the changes in myocardial strain that we had identified in those who received intravenous lipids was 
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explained by the association between intravenous lipids and aortic stiffness or whether these were independent phenomena. In a stepwise regression model with apical CS as the dependent variable and maximum neonatal cholesterol level and aortic PWV in young adult life as independent variables, both maximum cholesterol level (␤ϭϪ0.574, 95% CI Ϫ0.354 to Ϫ2.271, Pϭ0.010) and aortic PWV (␤ϭϪ0.410, 95% CI Ϫ0.468 to Ϫ0.874, Pϭ0.050) remained independent predictors of apical CS.
Discussion
This study demonstrates that intravenous lipid exposure during neonatal life of premature infants is related to changes in aortic and cardiac function in adult life. Furthermore, the impact on aortic stiffness and myocardial strain in these individuals is graded depending on the maximum cholesterol level attained and amount of time elevated during this early period of cardiovascular development. These associations are independent of native cholesterol levels during the first decades of life, suggesting that nutritional elevation of cholesterol in critical periods of early development may have a direct impact on the cardiovascular system. Premature infants are at risk of significant morbidity, and intravenous lipids are proven to be beneficial for neonatal brain and central nervous system development. 30 Therefore our findings are not of clinical relevance to the use of intravenous lipids in this setting. Rather, our interest related to the fact that because intravenous lipids consist of triglycerides emulsified by egg phospholipid and glycerol, they are known to lead to various hyperlipidemias, including hypercholesterolemia. 7,9,17 Thereby we were able to make use of this unique clinical situation to explore experimentally the impact of artificial modification of lipid levels early in life on the cardiovascular system. A particular strength of our cohort was that subjects had taken part in a randomized trial of milk feeding regimes at birth, and therefore other nutritional influences were controlled between groups. Furthermore, our cohort had the advantage of prospective follow-up over a 25-year period, with detailed biochemical data during the first 9 weeks of life, adolescence, and early adulthood.
A potential limitation might have been that other clinical factors related to the decision to give intravenous lipids also related to long-term differences in aortic and myocardial function. Therefore, rather than a comparison of premature infants who received intravenous lipids with those who did not, we designed a nested case-control study that used the detailed perinatal data we had available in our follow-up group to identify a control group matched for potential confounding characteristics and complications, including maternal history, pregnancy complications, and neonatal care. 16 This was possible because there was significant variation in clinical use of intravenous lipids at the time of the study between centers, and therefore an infant with the same clinical characteristics may or may not have received intravenous lipids. The detail of data collection also allowed us to assess pregnancy history and postnatal cortisol levels to determine whether our findings may relate to differences in glucocorticoid exposure pre or postnatally. 31 Furthermore, we studied thyroid hormone level (triiodothyronine) postnatally to ensure that this did not account for variation in cholesterol or cardiovascular end points. It is possible we did not identify some individuals with selective variation in thyroxine levels or subclinical hypothyroidism, characterized by increased thyroid-stimulating hormone. We are thus unable to exclude the possibility that some of the variation in lipid levels relates to subclinical hypothyroidism in certain individuals.
Our findings are consistent with the rise in endogenous cholesterol induced by the Intralipid being the key factor in the association, rather than other factors elevated by intravenous nutrition, such as circulating triglyceride, glucose, and phospholipid levels. Cholesterol level was the only parameter associated with cardiovascular function, and the association was heavily graded, supporting a dose effect. Our analysis of the association between the cholesterol curve over the 9 weeks and Intralipid use suggests that the maximum cholesterol level reflects circulating cholesterol levels during exposure to Intralipid and that this elevation in cholesterol is transitory, with a return to baseline levels after the initial intravenous lipid exposure. Despite these close associations, it is possible that other metabolic changes that we did not measure, which were induced by Intralipid and which are also exclusively reflected in the change in cholesterol level, may account for our findings. Intralipid administration results in an elevation of free cholesterol as a result of an exceeded capacity to clear phospholipid, likely in part due to saturation of the lecithin-cholesterol acyltransferase pathway. This leads to a rise in cholesteryl esters but greater proportional rise in phospholipid and free cholesterol in the form of lipoprotein X in the low-density lipoprotein fraction. Further work is needed to determine how this alteration in lipid profile and subsequent clearance by the neonate results in long-term changes in cardiac and vascular pathophysiology. 8 We studied aortic PWV as our primary end point as a gold standard measurement of global aortic stiffness. 11 Aortic PWV is known to be relevant to later cardiovascular outcome and improve cardiovascular risk prediction when combined with other cardiovascular risk factors. 11, 23, 32 Cardiovascular magnetic resonance provides an accurate and highly reproducible method for PWV measurement. 12, 28, 33 Because of direct visualization of the aorta, the measure accounts for aortic geometry and is unaffected by body size, in contrast to other noninvasive methods that rely on surface measures of distance between measurement sites. 34 Values of PWV depend on methodology used and vary with age. Our preterm and term-born control groups, not exposed to postnatal Intralipid, have comparable PWV measures to other similarly aged cohorts measured using cardiovascular magnetic resonance. 35, 36 In older cohorts using measures based on carotidfemoral tonometry, mean values as high as 9.3 m/s are reported. 11 We identified that those who received intravenous lipids had a 1.32 m/s (1.47 SD) greater PWV than the nonintravenous lipid group or full-term-born controls. Outcome data in relation to PWV are not yet available based on measures performed in young adulthood. Nonetheless, if this magnitude of difference is maintained into later life, we know from studies based on other methods for assessment of PWV that a 1 m/s increase in PWV relates to a 14% age-and sex-adjusted increase in total cardiovascular events in middle-aged and elderly individuals. 37 The difference we identified is greater than that associated with other risk factors, such as obesity 38 and smoking. 28 Familial hypercholesterolemia (FH) is a risk factor of particular interest to our study because this condition is associated with sustained abnormalities in lipid profile from early in life. However, there are distinct differences in the nature of the cholesterol elevation in this group as they have a greater proportion of cholesteryl esters in the low-density lipoprotein fraction over a longer period of time. 39 Thus, the pathobiological impact on cardiovascular phenotype may differ. Nevertheless, several groups have investigated the impact of FH on arterial stiffness in young subjects aged between adolescence and early adulthood 40 -42 using a range of validated arterial stiffness measures. 12, 43, 44 Riggio et al used a single-point method in the carotid arteries to measure PWV and showed that children with FH had a 0.61m/s higher PWV than controls. 40 Similarly, Cheng et al showed that after stratifying FH patients in their 30s by high and low cholesterol burden, those in the high cholesterol burden category had a similar magnitude difference in PWV, measured by brachial-ankle PWV, than controls. 41 Soljanlahti et al used cardiovascular magnetic resonance imaging 42 to assess the aorta in a group of FH patients aged 6 to 48 years. In contrast to the other studies, they found no difference in PWV. They report lower levels of stiffness than we demonstrate using cardiovascular magnetic resonance in our young adults. However, this is likely to relate to subtle methodological variation rather than a biological difference in their cohorts, as the authors report a significantly lower temporal resolution and different method to identify the arrival of the pulse wave that is likely to lower absolute levels of PWV. Rather, a key biological difference is that 72% of the FH patients were receiving statins for an average of 10 years, having started at a mean age of 27 years, whereas in both the Riggio et al 40 and Cheng et al 41 studies, the FH patients were untreated. Soljanlahti et al 42 suggest this as a potential explanation for an absence of any difference between the groups.
Aortic stiffness is biologically the most plausible intermediate cardiovascular phenotype to alter long-term following exposure to lipids. 23 We found the most significant changes in aortic stiffness in the abdominal aorta. Human post mortem studies have demonstrated that the abdominal aorta is one of the sites with the greatest amount of lipid deposition. 4, 6 Although fatty streaks tend to regress after the first year of life, our data are consistent with a hypothesis that the increased cholesterol evident within the abdominal aortic wall during this critical period has a long-term selective impact on this region of the aorta. The postnatal period in these premature infants represents a particularly sensitive period of aortic development that normally occurs during the last trimester. During this time, proportions of elastin and collagen, relevant to arterial stiffness, are established within the aortic wall. 45 Lipid exposure, and particularly cholesterol exposure, has been shown to downregulate elastin-collagen cross-linking in vitro in animal cell models. 46 Furthermore, Massaeli et al showed that cholesterol negatively affects the organization of actin and myosin in rabbit aortic vascular smooth muscle cells, relevant to contractility. 47 We speculate that postnatal exposure to lipids and resultant endogenous elevation in cholesterol levels in humans could have a similar impact on aortic development. Alternatively, the lipid exposure during this critical period may have a direct programming effect on lipid metabolism that leads to chronic changes in ability to handle a lipid load and persistently elevated postprandial cholesterol levels. We do not have data on postprandial lipids in later life to exclude this possibility, and therefore a valid alternative hypothesis would be that the changes in aortic and cardiac function are the result of this chronic, rather than acute, damage. Aortic stiffness is of particular relevance to blood pressure, 48 and the trend toward higher blood pressure in the Intralipid group may be an early indicator of changes that will amplify in the long term.
Our finding of a relationship between early lipid exposure and later myocardial function in humans is intriguing. Acute direct effects of a high-lipid diet on myocardial function have been reported in several animal models. 13, 14, 49 Whether such insults have long-term effects and are particularly influential during early stages of cardiac development has not been studied. We were able to include myocardial tagging as a sensitive marker of early changes in myocardial function in a proportion of our young adults. We demonstrated a graded association between Intralipid dose and length of exposure postnatally and reductions in myocardial apical peak systolic CS. As with our aortic measures, the associated elevation in cholesterol secondary to Intralipid infusion was the main mediator of the association and was related in a graded manner to apical systolic strain. This association was independent of that between aortic stiffness and myocardial strain. The perinatal stage is important for the increase in expression of cardiac specific sarco/endoplasmic reticulum Ca-ATPase (SERCA2) and ␣-and ␤-myosin heavy chain contractile proteins (fast and slow contractile ATPase activity, respectively). Huang et al showed that rabbits fed a high-lipid diet had a significant reduction in myocyte systolic contractile function, along with a downregulation of SERCA2 expression and a large increase in the ratio of ␤-myosin heavy chain to ␣-myosin heavy chain expression in the rabbit myocyte. 13 They concluded that altered calcium handling and myosin heavy chain expression explained the reduced myocyte contractility in the group fed the lipid-rich diet. Onody et al 49 have expressed similar findings, and it will be of interest to determine whether, in humans, Intralipid exposure during critical periods of early postnatal life has a similar negative impact on cardiac myocytes.
Cholesterol levels as early as the first few months of life are known to reflect cholesterol levels in later life, 29, 50 and our study demonstrates that a measure of minimum cholesterol within days of birth can predict fasting cholesterol levels in young adults. However, intravenous lipids led to a significantly higher level of cholesterol than in those who did not receive lipids, and the change in cholesterol was independent of native cholesterol levels during life. Further work is required to understand the relevance of our findings to the narrower nutritional variation in cholesterol in normal neonatal life. Our data showed a graded association between neonatal maximum cholesterol level and later cardiovascular function that extended throughout the range of cholesterol
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Neonatal Lipids and Adult Cardiovascular Functionlevels. However, although there was a positive graded association in the nonintravenous lipid group, this relationship did not reach significance. The variation in aortic stiffness in the nonintravenous lipid group was smaller and similar to the levels in the term control group, and a larger study will be needed to explore the impact of normal ranges of cholesterol in neonatal life on aortic function. The nutritional status of the pregnant mother may also be relevant for the wider population of term-born individuals as the period during which cholesterol was modified in our premature infants relates to a stage of aortic growth and development that usually occurs in utero during the last trimester. 6, 45 In conclusion, we have demonstrated that intravenous lipid administration leads to an artificial elevation of cholesterol level in immediate postnatal life, which is associated with long-term changes in aortic and myocardial function proportional to the degree of cholesterol elevation. The preterm neonatal period is particularly sensitive, and there is significant public health interest in the best management of these infants, as preterm birth accounts for 9.6% of all deliveries worldwide. 51 The public health relevance of our finding in the wider population also needs to be understood as, for the first time, we have demonstrated that nutrition high in lipids during sensitive periods of early human development has a long-term negative impact on the cardiovascular system.
